Opiate Withdrawal Syndrome Clinical Trial
Official title:
A Smartphone App to Facilitate Buprenorphine Discontinuation
The investigators propose to develop a smartphone app (called BetterOFF) that will help patients manage opioid withdrawal during opioid medication taper and detoxification. The BetterOFF smartphone intervention will be a resource patients can access anytime and anywhere. If the BetterOFF intervention were to be effective in helping patients discontinue opioid medication, it could be integrated into the standard of care of office-based clinical practices, as well as substance use programs, thereby having a substantial public health impact.
Many of the growing number of patients prescribed long-term opioid medication (for a variety of reasons including a history of illicit opioid use or management of chronic pain) will express an interest in discontinuing medication. However, many patients, physically dependent on opioids, fear the withdrawal symptoms that inevitably occur with opioid medication discontinuation and will experience a decrease in their self-efficacy for abstinence at the end of a taper. As a result, tapering is often slow and done hesitantly, and relapse rates after an opioid taper are high and associated with broad consequences, including significant negative physical, mental, and social problems. Even with optimal tapering protocols, patients need novel approaches to manage the discontinuation of opiate agonist treatment. Given this important gap in opioid treatment delivery, we propose to develop a theoretically-driven, smartphone-delivered intervention (Better Off app) to help patients effectively manage the experience of opioid medication discontinuation. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03975192 -
Neurostimulation for Opiate Withdrawal in the PICU
|
N/A | |
Completed |
NCT03521960 -
Buspirone for Opioid Tapering
|
Phase 1 | |
Enrolling by invitation |
NCT03012373 -
Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts
|
N/A | |
Completed |
NCT01945736 -
Pharmacokinetics of Multiple Dose Methadone in Children Treated for Opiate Withdrawal
|
||
Not yet recruiting |
NCT03397212 -
Treatment of Withdrawal Symptoms With NADA Acupuncture in Chronic Pain Patients
|
Phase 4 | |
Recruiting |
NCT05995535 -
Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
|
Phase 2 | |
Completed |
NCT05569031 -
Treatment of Withdrawal Symptoms and Prevention of Relapse in Patients With Tramadol Abuse
|
Phase 4 | |
Completed |
NCT03971097 -
The Effect of Self-Forgiveness on Self-Stigma in Addiction.
|
N/A | |
Recruiting |
NCT05029401 -
A Study of Oral Ibogaine in Opioid Withdrawal
|
Phase 1/Phase 2 |